234 related articles for article (PubMed ID: 22247786)
1. Integrated dataset of screening hits against multiple neglected disease pathogens.
Nwaka S; Besson D; Ramirez B; Maes L; Matheeussen A; Bickle Q; Mansour NR; Yousif F; Townson S; Gokool S; Cho-Ngwa F; Samje M; Misra-Bhattacharya S; Murthy PK; Fakorede F; Paris JM; Yeates C; Ridley R; Van Voorhis WC; Geary T
PLoS Negl Trop Dis; 2011 Dec; 5(12):e1412. PubMed ID: 22247786
[TBL] [Abstract][Full Text] [Related]
2. Recent Advances in Drug Discovery for Parasitic Diseases.
de Moraes J
Curr Top Med Chem; 2023; 23(9):711-712. PubMed ID: 37254528
[No Abstract] [Full Text] [Related]
3. Expanding Bromodomain Targeting into Neglected Parasitic Diseases.
Tallant C; Bamborough P; Chung CW; Gamo FJ; Kirkpatrick R; Larminie C; Martín J; Prinjha R; Rioja I; Simola DF; Gabarró R; Calderón F
ACS Infect Dis; 2021 Nov; 7(11):2953-2958. PubMed ID: 34612618
[TBL] [Abstract][Full Text] [Related]
4. Fragment-based screening in tandem with phenotypic screening provides novel antiparasitic hits.
Blaazer AR; Orrling KM; Shanmugham A; Jansen C; Maes L; Edink E; Sterk GJ; Siderius M; England P; Bailey D; de Esch IJ; Leurs R
J Biomol Screen; 2015 Jan; 20(1):131-40. PubMed ID: 25231971
[TBL] [Abstract][Full Text] [Related]
5. Innovative partnerships for drug discovery against neglected diseases.
Jakobsen PH; Wang MW; Nwaka S
PLoS Negl Trop Dis; 2011 Sep; 5(9):e1221. PubMed ID: 21980540
[No Abstract] [Full Text] [Related]
6. A Multilayer Network Approach for Guiding Drug Repositioning in Neglected Diseases.
Berenstein AJ; Magariños MP; Chernomoretz A; Agüero F
PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004300. PubMed ID: 26735851
[TBL] [Abstract][Full Text] [Related]
7. Price hikes could affect treatment for NTDs in the USA.
Nelson R
Lancet Infect Dis; 2018 Feb; 18(2):150-151. PubMed ID: 29412967
[No Abstract] [Full Text] [Related]
8. Ethical considerations in an era of mass drug administration.
Wharam B; Lazarou L
Parasit Vectors; 2013 Aug; 6():234. PubMed ID: 23937995
[TBL] [Abstract][Full Text] [Related]
9. Open Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and Beyond.
Van Voorhis WC; Adams JH; Adelfio R; Ahyong V; Akabas MH; Alano P; Alday A; Alemán Resto Y; Alsibaee A; Alzualde A; Andrews KT; Avery SV; Avery VM; Ayong L; Baker M; Baker S; Ben Mamoun C; Bhatia S; Bickle Q; Bounaadja L; Bowling T; Bosch J; Boucher LE; Boyom FF; Brea J; Brennan M; Burton A; Caffrey CR; Camarda G; Carrasquilla M; Carter D; Belen Cassera M; Chih-Chien Cheng K; Chindaudomsate W; Chubb A; Colon BL; Colón-López DD; Corbett Y; Crowther GJ; Cowan N; D'Alessandro S; Le Dang N; Delves M; DeRisi JL; Du AY; Duffy S; Abd El-Salam El-Sayed S; Ferdig MT; Fernández Robledo JA; Fidock DA; Florent I; Fokou PV; Galstian A; Gamo FJ; Gokool S; Gold B; Golub T; Goldgof GM; Guha R; Guiguemde WA; Gural N; Guy RK; Hansen MA; Hanson KK; Hemphill A; Hooft van Huijsduijnen R; Horii T; Horrocks P; Hughes TB; Huston C; Igarashi I; Ingram-Sieber K; Itoe MA; Jadhav A; Naranuntarat Jensen A; Jensen LT; Jiang RH; Kaiser A; Keiser J; Ketas T; Kicka S; Kim S; Kirk K; Kumar VP; Kyle DE; Lafuente MJ; Landfear S; Lee N; Lee S; Lehane AM; Li F; Little D; Liu L; Llinás M; Loza MI; Lubar A; Lucantoni L; Lucet I; Maes L; Mancama D; Mansour NR; March S; McGowan S; Medina Vera I; Meister S; Mercer L; Mestres J; Mfopa AN; Misra RN; Moon S; Moore JP; Morais Rodrigues da Costa F; Müller J; Muriana A; Nakazawa Hewitt S; Nare B; Nathan C; Narraidoo N; Nawaratna S; Ojo KK; Ortiz D; Panic G; Papadatos G; Parapini S; Patra K; Pham N; Prats S; Plouffe DM; Poulsen SA; Pradhan A; Quevedo C; Quinn RJ; Rice CA; Abdo Rizk M; Ruecker A; St Onge R; Salgado Ferreira R; Samra J; Robinett NG; Schlecht U; Schmitt M; Silva Villela F; Silvestrini F; Sinden R; Smith DA; Soldati T; Spitzmüller A; Stamm SM; Sullivan DJ; Sullivan W; Suresh S; Suzuki BM; Suzuki Y; Swamidass SJ; Taramelli D; Tchokouaha LR; Theron A; Thomas D; Tonissen KF; Townson S; Tripathi AK; Trofimov V; Udenze KO; Ullah I; Vallieres C; Vigil E; Vinetz JM; Voong Vinh P; Vu H; Watanabe NA; Weatherby K; White PM; Wilks AF; Winzeler EA; Wojcik E; Wree M; Wu W; Yokoyama N; Zollo PH; Abla N; Blasco B; Burrows J; Laleu B; Leroy D; Spangenberg T; Wells T; Willis PA
PLoS Pathog; 2016 Jul; 12(7):e1005763. PubMed ID: 27467575
[TBL] [Abstract][Full Text] [Related]
10. Yeast-based high-throughput screens for discovery of kinase inhibitors for neglected diseases.
Tavella TA; Cassiano GC; Costa FTM; Sunnerhagen P; Bilsland E
Adv Protein Chem Struct Biol; 2021; 124():275-309. PubMed ID: 33632468
[TBL] [Abstract][Full Text] [Related]
11. Dual Inhibition of Parasitic Targets: A Valuable Strategy to Treat Malaria and Neglected Tropical Diseases.
Previti S; Di Chio C; Ettari R; Zappalà M
Curr Med Chem; 2022; 29(17):2952-2978. PubMed ID: 34375176
[TBL] [Abstract][Full Text] [Related]
12. Target assessment for antiparasitic drug discovery.
Frearson JA; Wyatt PG; Gilbert IH; Fairlamb AH
Trends Parasitol; 2007 Dec; 23(12):589-95. PubMed ID: 17962072
[TBL] [Abstract][Full Text] [Related]
13. Current antiparasitic drug targets and a paradigm shift in discovery of new antiparasitic drugs and vaccines.
Tekwani BL
Curr Drug Targets; 2008 Nov; 9(11):921. PubMed ID: 18991603
[No Abstract] [Full Text] [Related]
14. Systemic and Target-Site Pharmacokinetics of Antiparasitic Agents.
Al Jalali V; Zeitlinger M
Clin Pharmacokinet; 2020 Jul; 59(7):827-847. PubMed ID: 32100246
[TBL] [Abstract][Full Text] [Related]
15. Drug discovery for infectious agents causing neglected diseases.
Silber AM; Pereira CA; Wrenger C
Curr Med Chem; 2014; 21(15):1667. PubMed ID: 24304273
[No Abstract] [Full Text] [Related]
16. Structure-Based Targeting of Orthologous Pathogen Proteins Accelerates Antiparasitic Drug Discovery.
Jain V; Sharma A; Singh G; Yogavel M; Sharma A
ACS Infect Dis; 2017 Apr; 3(4):281-292. PubMed ID: 28195698
[TBL] [Abstract][Full Text] [Related]
17. Fragment-based screening with natural products for novel anti-parasitic disease drug discovery.
Liu M; Quinn RJ
Expert Opin Drug Discov; 2019 Dec; 14(12):1283-1295. PubMed ID: 31512943
[No Abstract] [Full Text] [Related]
18. High Throughput and Computational Repurposing for Neglected Diseases.
Hernandez HW; Soeung M; Zorn KM; Ashoura N; Mottin M; Andrade CH; Caffrey CR; de Siqueira-Neto JL; Ekins S
Pharm Res; 2018 Dec; 36(2):27. PubMed ID: 30560386
[TBL] [Abstract][Full Text] [Related]
19. Transgenic parasites accelerate drug discovery.
Rodriguez A; Tarleton RL
Trends Parasitol; 2012 Mar; 28(3):90-2. PubMed ID: 22277131
[TBL] [Abstract][Full Text] [Related]
20. Yeast as a potential vehicle for neglected tropical disease drug discovery.
Denny PW; Steel PG
J Biomol Screen; 2015 Jan; 20(1):56-63. PubMed ID: 25121554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
